Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus
Validez del módulo TDAH de Mini-International Neuropsychiatric Interview PLUS para cribar TDAH en adultos en pacientes con trastornos por abuso de sustancias que buscan tratamiento
Options
BORIS DOI
Publisher DOI
PubMed ID
32561156
Description
Objective: This study aims to assess the validity of the ADHD module of the Mini-International Neuropsychiatric Interview (MINI-Plus) in patients with substance use disorders (SUD), using the Conners' Adult ADHD Diagnostic Interview for DSM-IV (CAADID) as the external criterion.
Method: A cross sectional international multi-center study in 10 countries was conducted in treatment seeking SUD patients. A sample of 1263 patients with both MINI-Plus and CAADID was analyzed to determine the psychometric properties of the MINI-Plus.
Results: According to the CAADID, 179 patients (14.2%) met criteria for adult ADHD, whereas according to the MINI-Plus 227 patients (18.0%) were identified as having adult ADHD. Sensitivity of the MINI-Plus ADHD module was 74%, specificity was 91%, positive predictive value was 60% and negative predictive value was 96%. Kappa was 0.60.
Conclusion: The MINI-Plus has acceptable criterion validity for the screening of adult ADHD in treatment seeking SUD patients.
Scientific significance: On the basis of the results, The MINI-Plus may be used for the screening of ADHD in SUD patients.
Method: A cross sectional international multi-center study in 10 countries was conducted in treatment seeking SUD patients. A sample of 1263 patients with both MINI-Plus and CAADID was analyzed to determine the psychometric properties of the MINI-Plus.
Results: According to the CAADID, 179 patients (14.2%) met criteria for adult ADHD, whereas according to the MINI-Plus 227 patients (18.0%) were identified as having adult ADHD. Sensitivity of the MINI-Plus ADHD module was 74%, specificity was 91%, positive predictive value was 60% and negative predictive value was 96%. Kappa was 0.60.
Conclusion: The MINI-Plus has acceptable criterion validity for the screening of adult ADHD in treatment seeking SUD patients.
Scientific significance: On the basis of the results, The MINI-Plus may be used for the screening of ADHD in SUD patients.
Date of Publication
2023
Publication Type
Article
Subject(s)
Keyword(s)
ADHD
•
Comorbidity
•
Substance use disorder
•
MINI
•
Psychometrics
Language(s)
en
Contributor(s)
Palma-Álvarez, Raul Felipe | |
Barta, Csaba | |
Carpentier, Pieter Jan | |
Carruthers, Susan | |
Crunelle, Cleo L. | |
Demetrovics, Zsolt | |
Dom, Geert | |
Faraone, Stephen V. | |
Franck, Johan | |
Johnson, Brian | |
Kapitány-Fövény, Máté | |
Kaye, Sharlene | |
Konstenius, Maija | |
Matthys, Frieda | |
Møller, Merete | |
Schellekens, Arnt | |
Skutle, Arvid | |
van de Glind, Geurt | |
van Emmerik-van Oortmerssen, Katelijne | |
Verspreet, Sofie | |
Schoevers, Robert A. | |
Wallhed, Sara | |
Levin, Frances R. | |
Grau-López, Lara | |
Casas, Miguel | |
van den Brink, Wim | |
Ramos-Quiroga, Josep Antoni |
Series
Revista de Psiquiatría y Salud Mental
Publisher
Elsevier España
ISSN
1888-9891
Access(Rights)
open.access